Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
57:46
January 23, 2026 - PBS News Hour full episode
57:46
January 22, 2026 - PBS News Hour full episode
57:46
January 21, 2026 - PBS News Hour full episode
57:46
January 20, 2026 - PBS News Hour full episode
57:46
January 19, 2026 - PBS News Hour full episode
57:46
January 16, 2026 - PBS News Hour full episode
56:46
January 15, 2026 - PBS News Hour full episode
57:46
January 14, 2026 - PBS News Hour full episode
57:46
January 13, 2026 - PBS News Hour full episode
57:46
January 12, 2026 - PBS News Hour full episode
26:52
January 11, 2026 - PBS News Weekend full episode
26:44
January 10, 2026 - PBS News Weekend full episode